Redirecting splicing with bifunctional oligonucleotides

Nucleic Acids Research

Volumn 42, Issue 6, 2014, Pages

  Brosseau, Jean Philippe ^a,b   Lucier, Jean François ^a,b   Lamarche, Andrée Anne ^b   Shkreta, Lulzim ^b   Gendron, Daniel ^a   Lapointe, Elvy ^a   Thibault, Philippe ^a   Paquet, Éric ^a   Perreault, Jean Pierre ^a,b   Elela, Sherif Abou ^a,b   Chabot, Benoit ^a,b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHMS; ALTERNATIVE SPLICING; CELL LINE; DNA-BINDING PROTEINS; EXONS; HELA CELLS; HUMANS; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; RNA SPLICE SITES;

EID: 84898976231     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1287     Document Type: Article

References (52)

1. Pan, Q., Shai, O., Lee, L. J., Frey, B. J. and Blencowe, B. J. (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet., 40, 1413-1415.
2. Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P. and Burge, C. B. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature, 456, 470-476.
3. Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F. et al. (2012) Landscape of transcription in human cells. Nature, 489, 101-108.
4. Nilsen, T. W. and Graveley, B. R. (2010) Expansion of the eukaryotic proteome by alternative splicing. Nature, 463, 457-463.
5. Tazi, J., Bakkour, N. and Stamm, S. (2009) Alternative splicing and disease. Biochim. Biophys. Acta, 1792, 14-26.
6. Venables, J. P., Klinck, R., Koh, C., Gervais-Bird, J., Bramard, A., Inkel, L., Durand, M., Couture, S., Froehlich, U., Lapointe, E. et al. (2009) Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol., 16, 670-676.
7. Lopez-Bigas, N., Audit, B., Ouzounis, C., Parra, G. and Guigo, R. (2005) Are splicing mutations the most frequent cause of hereditary disease? FEBS Lett., 579, 1900-1903.
8. Park, J. W., Parisky, K., Celotto, A. M., Reenan, R. A. and Graveley, B. R. (2004) Identification of alternative splicing regulators by RNA interference in Drosophila. Proc. Natl Acad. Sci. U. S. A., 101, 15974-15979.
9. Dominski, Z. and Kole, R. (1993) Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc. Natl Acad. Sci. U. S. A., 90, 8673-8677.
10. Zammarchi, F., de Stanchina, E., Bournazou, E., Supakorndej, T., Martires, K., Riedel, E., Corben, A. D., Bromberg, J. F. and Cartegni, L. (2011) Antitumorigenic potential of STAT3 alternative splicing modulation. Proc. Natl Acad. Sci. U. S. A., 108, 17779-17784.
11. Garcia-Blanco, M. A. (2006) Alternative splicing: therapeutic target and tool. Prog. Mol. Subcell. Biol., 44, 47-64.
12. Kole, R., Krainer, A. R. and Altman, S. (2012) RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat. Rev. Drug Discov., 11, 125-140.
13. Singh, N. K., Singh, N. N., Androphy, E. J. and Singh, R. N. (2006) Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Mol. Cell. Biol., 26, 1333-1346.
14. Hua, Y., Vickers, T. A., Baker, B. F., Bennett, C. F. and Krainer, A. R. (2007) Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. PLoS Biol., 5, e73.
15. Gallagher, T. L., Arribere, J. A., Geurts, P. A., Exner, C. R., McDonald, K. L., Dill, K. K., Marr, H. L., Adkar, S. S., Garnett, A. T., Amacher, S. L. et al. (2011) Rbfox-regulated alternative splicing is critical for zebrafish cardiac and skeletal muscle functions. Dev. Biol., 359, 251-261.
16. Hua, Y., Sahashi, K., Hung, G., Rigo, F., Passini, M. A., Bennett, C. F. and Krainer, A. R. (2010) Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. Genes Dev., 24, 1634-1644.
17. Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F. and Krainer, A. R. (2011) Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature, 478, 123-126.
18. Hua, Y., Vickers, T. A., Okunola, H. L., Bennett, C. F. and Krainer, A. R. (2008) Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am. J. Hum. Genet., 82, 834-848.
19. Spitali, P. and Aartsma-Rus, A. (2012) Splice modulating therapies for human disease. Cell, 148, 1085-1088.
20. Cirak, S., Feng, L., Anthony, K., Arechavala-Gomeza, V., Torelli, S., Sewry, C., Morgan, J. E. and Muntoni, F. (2012) Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy. Mol. Ther., 20, 462-467.
21. Lu, Q. L., Rabinowitz, A., Chen, Y. C., Yokota, T., Yin, H., Alter, J., Jadoon, A., Bou-Gharios, G. and Partridge, T. (2005) Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc. Natl Acad. Sci. U. S. A., 102, 198-203.
22. Wu, B., Moulton, H. M., Iversen, P. L., Jiang, J., Li, J., Li, J., Spurney, C. F., Sali, A., Guerron, A. D., Nagaraju, K. et al. (2008) Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer. Proc. Natl Acad. Sci. U. S. A., 105, 14814-14819.
23. Villemaire, J., Dion, I., Elela, S. A. and Chabot, B. (2003) Reprogramming alternative pre-messenger RNA splicing through the use of protein-binding antisense oligonucleotides. J. Biol. Chem., 278, 50031-50039.
24. Gendron, D., Carriero, S., Garneau, D., Villemaire, J., Klinck, R., Elela, S. A., Damha, M. J. and Chabot, B. (2006) Modulation of 50 splice site selection using tailed oligonucleotides carrying splicing signals. BMC Biotechnol., 6, 5.
25. Dickson, A., Osman, E. and Lorson, C. L. (2008) A negatively acting bifunctional RNA increases survival motor neuron both in vitro and in vivo. Hum. Gene Ther., 19, 1307-1315.
26. Martinez-Contreras, R., Cloutier, P., Shkreta, L., Fisette, J. F., Revil, T. and Chabot, B. (2007) hnRNP proteins and splicing control. Adv. Exp. Med. Biol., 623, 123-147.
27. Garcia-Blanco, M. A., Baraniak, A. P. and Lasda, E. L. (2004) Alternative splicing in disease and therapy. Nat. Biotechnol., 22, 535-546.
28. Skordis, L. A., Dunckley, M. G., Yue, B., Eperon, I. C. and Muntoni, F. (2003) Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proc. Natl Acad. Sci. U. S. A., 100, 4114-4119.
29. Cartegni, L. and Krainer, A. R. (2003) Correction of diseaseassociated exon skipping by synthetic exon-specific activators. Nat. Struct. Biol., 10, 120-125.
30. Marquis, J., Meyer, K., Angehrn, L., Kampfer, S. S., Rothen-Rutishauser, B. and Schumperli, D. (2007) Spinal muscular atrophy: SMN2 pre-mRNA splicing corrected by a U7 snRNA derivative carrying a splicing enhancer sequence. Mol. Ther., 15, 1479-1486.
31. Venables, J. P., Brosseau, J. P., Gadea, G., Klinck, R., Prinos, P., Beaulieu, J. F., Lapointe, E., Durand, M., Thibault, P., Tremblay, K. et al. (2013) RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues. Mol. Cell. Biol., 33, 396-405.
32. Prinos, P., Garneau, D., Lucier, J. F., Gendron, D., Couture, S., Boivin, M., Brosseau, J. P., Lapointe, E., Thibault, P., Durand, M. et al. (2011) Alternative splicing of SYK regulates mitosis and cell survival. Nat. Struct. Mol. Biol., 18, 673-679.
33. Brosseau, J. P., Lucier, J. F., Lapointe, E., Durand, M., Gendron, D., Gervais-Bird, J., Tremblay, K., Perreault, J. P. and Elela, S. A. (2010) High-throughput quantification of splicing isoforms. RNA, 16, 442-449.
34. Klinck, R., Bramard, A., Inkel, L., Dufresne-Martin, G., Gervais-Bird, J., Madden, R., Paquet, E. R., Koh, C., Venables, J. P., Prinos, P. et al. (2008) Multiple alternative splicing markers for ovarian cancer. Cancer Res., 68, 657-663.
35. Chabot, B., Blanchette, M., Lapierre, I. and La Branche, H. (1997) An intron element modulating 50 splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1. Mol. Cell. Biol., 17, 1776-1786.
36. Dignam, J. D., Lebovitz, R. M. and Roeder, R. G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475-1489.
37. Brosseau, J.-P. (2012) Ph. D. Thesis, Université de Sherbrooke, De'tection, annotation fonctionnelle et re'gulation des isoformes de l'e'pissage alternatif associe'es au cancer de l'ovaire.
38. Markham, N. R. and Zuker, M. (2008) UNAFold: software for nucleic acid folding and hybridization. Methods Mol. Biol., 453, 3-31.
39. Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A. et al. (2005) Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med., 11, 263-270.
40. Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K. and MacLachlan, I. (2005) Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRN A. Nat. Biotechnol., 23, 457-462.
41. Fedorov, Y., Anderson, E. M., Birmingham, A., Reynolds, A., Karpilow, J., Robinson, K., Leake, D., Marshall, W. S. and Khvorova, A. (2006) Off-target effects by siRNA can induce toxic phenotype. RNA, 12, 1188-1196.
42. Pei, Y. and Tuschl, T. (2006) On the art of identifying effective and specific siRNAs. Nat. Methods, 3, 670-676.
43. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. and Lipman, D. J. (1990) Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
44. Thierry-Mieg, D. and Thierry-Mieg, J. (2006) AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol., 7(Suppl. 1), S12.11-14.
45. Stadler, M. B., Shomron, N., Yeo, G. W., Schneider, A., Xiao, X. and Burge, C. B. (2006) Inference of splicing regulatory activities by sequence neighborhood analysis. PLoS Genet., 2, e191.
46. Buratti, E. and Baralle, F. E. (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem., 276, 36337-36343.
47. Simard, M. J. and Chabot, B. (2000) Control of hnRNP A1 alternative splicing: an intron element represses use of the common 30 splice site. Mol. Cell. Biol., 20, 7353-7362.
48. Allo, M., Buggiano, V., Fededa, J. P., Petrillo, E., Schor, I., de la Mata, M., Agirre, E., Plass, M., Eyras, E., Elela, S. A. et al. (2009) Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat. Struct. Mol. Biol., 16, 717-724.
49. Martinez-Contreras, R., Fisette, J. F., Nasim, F. U., Madden, R., Cordeau, M. and Chabot, B. (2006) Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate pre-mRNA splicing. PLoS Biol., 4, e21.
50. Nasim, F. U., Hutchison, S., Cordeau, M. and Chabot, B. (2002) High-affinity hnRNP A1 binding sites and duplex-forming inverted repeats have similar effects on 50 splice site selection in support of a common looping out and repression mechanism. RNA, 8, 1078-1089.
51. Blanchette, M. and Chabot, B. (1999) Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J., 18, 1939-1952.
52. Passoni, M., De Conti, L., Baralle, M. and Buratti, E. (2012) UG repeats/TDP-43 interactions near 50 splice sites exert unpredictable effects on splicing modulation. J. Mol. Biol., 415, 46-60.